Skip to main content

Advertisement

SpringerLink
Log in

Five critical elements to ensure the precision medicine

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

The precision medicine as a new emerging area and therapeutic strategy has occurred and was practiced in the individual and brought unexpected successes, and gained high attentions from professional and social aspects as a new path to improve the treatment and prognosis of patients. There will be a number of new components to appear or be discovered, of which clinical bioinformatics integrates clinical phenotypes and informatics with bioinformatics, computational science, mathematics, and systems biology. In addition to those tools, precision medicine calls more accurate and repeatable methodologies for the identification and validation of gene discovery. Precision medicine will bring more new therapeutic strategies, drug discovery and development, and gene-oriented treatment. There is an urgent need to identify and validate disease-specific, mechanism-based, or epigenetics-dependent biomarkers to monitor precision medicine, and develop “precision” regulations to guard the application of precision medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. The New England Journal of Medicine. doi:10.1056/NEJMp1500523.

    Google Scholar 

  2. Mirnezami, R., Nicholson, J., & Darzi, A. (2012). Preparing for precision medicine. The New England Journal of Medicine, 366, 489–491. doi:10.1056/NEJMp1114866.

    Article  PubMed  Google Scholar 

  3. Wang, X. D., & Liotta, L. (2011). Clinical bioinformatics: a new emerging science. Journal of Clinical Bioinformatics, 1(1), 1. doi:10.1186/2043-9113-1-1.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Wu, X., Sun, X., Chen, C., Bai, C., & Wang, X. D. (2014). Dynamic gene expressions of peripheral blood mononuclear cells in patients with acute exacerbation of chronic obstructive pulmonary disease: a preliminary study. Critical Care, 18(6), 508.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Chen, H., Wang, Y., Bai, C., & Wang, X. D. (2012). Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. Journal of Proteomics, 75(10), 2835–2843. doi:10.1016/j.jprot.2012.01.027.

    Article  CAS  PubMed  Google Scholar 

  6. Chen, H., Song, Z., Qian, M., Bai, C., & Wang, X. D. (2012). Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. Journal of Cellular and Molecular Medicine, 16(6), 1286–1297. doi:10.1111/j.1582-4934.2011.01416.x.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Handelsman, J. (2015). Precision medicine: improving health and treating disease. Statement in Office of Science and Technology Policy. www.whitehouse.gov/blog/2015/01/21/precision-medicine-improving-health-and-treating-disease.

  8. Ding, L., Wend, M. C., McMichael, J. F., & Raphael, B. J. (2014). Expanding the computational toolbox for mining cancer genomes. Nature Reviews Genetics, 15(8), 556–570. doi:10.1038/nrg3767.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Klauschen, F., Andreeff, M., Keilholz, U., Dietel, M., & Stenzinger, A. (2014). The combinatorial complexity of cancer precision medicine. Oncoscience, 1(7), 504–509.

    PubMed Central  PubMed  Google Scholar 

  10. Dolsten, M., & Søgaard, M. (2012). Precision medicine: an approach to R&D for delivering superior medicines to patients. Clinical and Translational Medicine, 1(1), 7. doi:10.1186/2001-1326-1-7.

  11. Wilky, B. A., Rudek, M. A., Ahmed, S., Laheru, D. A., Cosgrove, D., Donehower, R. C., et al. (2015). A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours. British Journal of Cancer, 112(1), 24–31. doi:10.1038/bjc.2014.515.

    Article  CAS  PubMed  Google Scholar 

  12. Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., et al. (2015). Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature, 517(7533), 205–208. doi:10.1038/nature13828.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Wang, X. D., Andersson, R., Soltesz, V., & Bengmark, S. (1992). Bacterial translocation after major hepatectomy in patients and rats. Archives of Surgery, 127, 1101–1106.

    Article  CAS  PubMed  Google Scholar 

  14. Wang, X. D., Andersson, R., Soltesz, V., Guo, W., & Bengmark, S. (1993). Water-soluble ethylhydroxyethyl cellulose prevents bacterial translocation induced by major liver resection in the rat. Annals of Surgery, 217, 155–167.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Wan, X. D., & Ward, P. A. (2012). Opportunities and challenges of disease biomarkers: a new section in the journal of translational medicine. Journal of Translational Medicine, 10, 220. doi:10.1186/1479-5876-10-220.

    Article  Google Scholar 

  16. Montero, J., Sarosiek, K. A., DeAngelo, J. D., Maertens, O., Ryan, J., Ercan, D., et al. (2015). Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell, 160(5), 977–989. doi:10.1016/j.cell.2015.01.042.

    Article  CAS  PubMed  Google Scholar 

  17. Westcott, P. M., Halliwill, K. D., To, M. D., Rashid, M., Rust, A. G., Keane, T. M., et al. (2015). The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature, 517(7535), 489–492. doi:10.1038/nature13898.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Lander, E. S. (2015). Cutting the Gordian helix—regulating genomic testing in the era of precision medicine. The New England Journal of Medicine. doi:10.1056/NEJMp1501964.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Wenzhou Medical University affiliated The First Hospital, Wenzhou, China

    Chengshui Chen & Xiangdong Wang

  2. Zhongshan Hospital, Shanghai Institute of Clinical Bioinformatics, Fudan University Center for Clinical Bioinformatics, Shanghai, China

    Mingyan He, Yichun Zhu & Lin Shi

Authors
  1. Chengshui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mingyan He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yichun Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lin Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiangdong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiangdong Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, C., He, M., Zhu, Y. et al. Five critical elements to ensure the precision medicine. Cancer Metastasis Rev 34, 313–318 (2015). https://doi.org/10.1007/s10555-015-9555-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-015-9555-3

Keywords

Search

Navigation